{"disease":{"id":"opiod-use-disorder","name":"opiod use disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07498322","title":"Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":271031,"lead_sponsor_name":"University of Illinois at Chicago","has_results":false},{"nct_id":"NCT07457489","title":"Vanderbilt Integrated Community TMS for Opioid Recovery","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT07085351","title":"EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications","phase":"","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"University of Illinois at Chicago","has_results":false},{"nct_id":"NCT03831971","title":"The Influence of ANS-6637 on Midazolam Pharmacokinetics in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":true},{"nct_id":"NCT05304364","title":"Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Delpor, Inc.","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}